• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Interleukin-29 profiles in COVID-19 patients: Survival is associated with IL-29 levels.

作者信息

Fallah Vastani Zahra, Ahmadi Alireza, Abounoori Mahdi, Rouhi Ardeshiri Motahareh, Masoumi Elham, Ahmadi Iraj, Davodian Abdollah, Kaffashian Mohammadreza, Kenarkoohi Azra, Falahi Shahab, Mami Sanaz, Mami Sajad

机构信息

Student Research committee, Department of Laboratory Sciences, Faculty of Allied Medical Sciences Ilam University of Medical Sciences Ilam Iran.

Student Research Committee, School of Medicine Mazandaran University of Medical Sciences Sari Iran.

出版信息

Health Sci Rep. 2022 Mar 9;5(2):e544. doi: 10.1002/hsr2.544. eCollection 2022 Mar.

DOI:10.1002/hsr2.544
PMID:35284646
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8907560/
Abstract
摘要

相似文献

1
Interleukin-29 profiles in COVID-19 patients: Survival is associated with IL-29 levels.新冠病毒肺炎患者的白细胞介素-29特征：生存与白细胞介素-29水平相关。
Health Sci Rep. 2022 Mar 9;5(2):e544. doi: 10.1002/hsr2.544. eCollection 2022 Mar.
2
Characterization of the inflammatory response to COVID-19 illness in pregnancy.探讨 COVID-19 疾病在妊娠期间引发的炎症反应特征。
Cytokine. 2023 Oct;170:156319. doi: 10.1016/j.cyto.2023.156319. Epub 2023 Aug 4.
3
High levels of pro-inflammatory SARS-CoV-2-specific biomarkers revealed by in vitro whole blood cytokine release assay (CRA) in recovered and long-COVID-19 patients.在康复和长新冠患者的体外全血细胞因子释放试验（CRA）中发现高水平的促炎 SARS-CoV-2 特异性生物标志物。
PLoS One. 2023 Apr 5;18(4):e0283983. doi: 10.1371/journal.pone.0283983. eCollection 2023.
4
Distinct Immunological Profiles Help in the Maintenance of Salivary Secretory IgA Production in Mild Symptoms COVID-19 Patients.不同的免疫特征有助于维持 COVID-19 轻症患者的唾液分泌型免疫球蛋白 A 产生。
Front Immunol. 2022 May 24;13:890887. doi: 10.3389/fimmu.2022.890887. eCollection 2022.
5
Proinflammatory Cytokine Profiles in Both Mild Symptomatic and Asymptomatic SARS-CoV-2-Infected Egyptian Individuals and a Proposed Relationship to Post-COVID-19 Sequela.埃及轻症和无症状 SARS-CoV-2 感染个体的促炎细胞因子谱与新冠后后遗症的相关性研究
Viral Immunol. 2023 Nov;36(9):600-609. doi: 10.1089/vim.2023.0060. Epub 2023 Oct 13.
6
Evaluation of Free Light Chains (FLCs) Synthesis in Response to Exposure to SARS-CoV-2.评估 SARS-CoV-2 暴露后游离轻链（FLC）的合成。
Int J Mol Sci. 2022 Sep 30;23(19):11589. doi: 10.3390/ijms231911589.
7
Enhanced Severe Acute Respiratory Syndrome Coronavirus 2 Antigen-Specific Systemic Immune Responses in Multisystem Inflammatory Syndrome in Children and Reversal After Recovery.儿童多系统炎症综合征中增强的严重急性呼吸综合征冠状病毒 2 抗原特异性全身免疫应答及其恢复后逆转
J Infect Dis. 2022 Sep 28;226(7):1215-1223. doi: 10.1093/infdis/jiac304.
8
Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort study.疫苗接种状态对美国 SARS-CoV-2 感染后炎症反应动力学的影响：一项前瞻性队列研究。
Lancet Microbe. 2023 Sep;4(9):e692-e703. doi: 10.1016/S2666-5247(23)00171-4. Epub 2023 Aug 7.
9
The Relation of the Viral Structure of SARS-CoV-2, High-Risk Condition, and Plasma Levels of IL-4, IL-10, and IL-15 in COVID-19 Patients Compared to SARS and MERS Infections.SARS-CoV-2 病毒结构、高危条件与 COVID-19 患者血浆中 IL-4、IL-10 和 IL-15 水平的关系与 SARS 和 MERS 感染的比较。
Curr Mol Med. 2022;22(7):584-593. doi: 10.2174/1566524021666211004110101.
10
Robust long-term immunity to SARS-CoV-2 in patients recovered from severe COVID-19 after interleukin-6 blockade.在接受白细胞介素 6 阻断治疗后从重症 COVID-19 中康复的患者中对 SARS-CoV-2 具有强大的长期免疫力。
EBioMedicine. 2022 Aug;82:104153. doi: 10.1016/j.ebiom.2022.104153. Epub 2022 Jul 8.

引用本文的文献

1
Risk Factors of COVID-19 associated mucormycosis in Iranian patients: a multicenter study.伊朗 COVID-19 相关毛霉菌病患者的危险因素：一项多中心研究。
BMC Infect Dis. 2024 Aug 22;24(1):852. doi: 10.1186/s12879-024-09755-6.
2
Real-time impact of COVID-19 pandemic on cutaneous leishmaniasis case finding and strategic planning, preventive interventions, control and epidemiology in a region with a high burden of cutaneous leishmaniasis and COVID-19: A cross-sectional descriptive study based on registry data in Ilam-Iran.2019冠状病毒病大流行对皮肤利什曼病病例发现及战略规划、预防干预措施、控制和流行病学的实时影响：基于伊朗伊拉姆登记数据的横断面描述性研究，该地区皮肤利什曼病和2019冠状病毒病负担较重
Health Sci Rep. 2023 Aug 16;6(8):e1489. doi: 10.1002/hsr2.1489. eCollection 2023 Aug.
3

本文引用的文献

1
Identification of risk factors for mortality associated with COVID-19.新型冠状病毒肺炎（COVID-19）相关死亡风险因素的识别
PeerJ. 2020 Sep 1;8:e9885. doi: 10.7717/peerj.9885. eCollection 2020.
2
Immunology of COVID-19: Current State of the Science.COVID-19 的免疫学：科学现状。
Immunity. 2020 Jun 16;52(6):910-941. doi: 10.1016/j.immuni.2020.05.002. Epub 2020 May 6.
3
Clinical characteristics of Coronavirus Disease 2019 and development of a prediction model for prolonged hospital length of stay.2019冠状病毒病的临床特征及住院时间延长预测模型的建立
IFNλ: balancing the light and dark side in pulmonary infection.IFNλ：平衡肺部感染中的明暗两面。
mBio. 2023 Aug 31;14(4):e0285022. doi: 10.1128/mbio.02850-22. Epub 2023 Jun 6.
4
Systematic levels of IL-29 and microRNA185-5p were not associated with severe COVID-19 in the Iranian population.伊朗人群中白细胞介素-29 和 microRNA185-5p 的系统水平与严重 COVID-19 无关。
Virol J. 2023 May 5;20(1):88. doi: 10.1186/s12985-023-02046-7.
5
Maternal COVID-19 infection and the fetus: Immunological and neurological perspectives.孕妇感染新冠病毒与胎儿：免疫学和神经学视角
New Microbes New Infect. 2023 Jun;53:101135. doi: 10.1016/j.nmni.2023.101135. Epub 2023 Apr 27.
Ann Transl Med. 2020 Apr;8(7):443. doi: 10.21037/atm.2020.03.147.
4
COVID-19: Immunology and treatment options.新型冠状病毒肺炎：免疫学与治疗选择。
Clin Immunol. 2020 Jun;215:108448. doi: 10.1016/j.clim.2020.108448. Epub 2020 Apr 27.
5
Weak Induction of Interferon Expression by Severe Acute Respiratory Syndrome Coronavirus 2 Supports Clinical Trials of Interferon-λ to Treat Early Coronavirus Disease 2019.严重急性呼吸综合征冠状病毒2对干扰素表达的弱诱导作用支持了干扰素λ治疗早期2019冠状病毒病的临床试验。
Clin Infect Dis. 2020 Sep 12;71(6):1410-1412. doi: 10.1093/cid/ciaa453.
6
Drug targets for corona virus: A systematic review.冠状病毒的药物靶点：系统评价。
Indian J Pharmacol. 2020 Jan-Feb;52(1):56-65. doi: 10.4103/ijp.IJP_115_20. Epub 2020 Mar 11.
7
Insights into IL-29: Emerging role in inflammatory autoimmune diseases.IL-29 研究进展：在炎症性自身免疫性疾病中的新作用
J Cell Mol Med. 2019 Dec;23(12):7926-7932. doi: 10.1111/jcmm.14697. Epub 2019 Oct 2.
8
Shared and Distinct Functions of Type I and Type III Interferons.I 型和 III 型干扰素的共有和独特功能。
Immunity. 2019 Apr 16;50(4):907-923. doi: 10.1016/j.immuni.2019.03.025.
9
Interferon-λ Mediates Non-redundant Front-Line Antiviral Protection against Influenza Virus Infection without Compromising Host Fitness.干扰素-λ 通过非冗余的一线抗病毒保护作用来抵抗流感病毒感染，而不损害宿主的适应性。
Immunity. 2017 May 16;46(5):875-890.e6. doi: 10.1016/j.immuni.2017.04.025.
10
The role of IL-29 in immunity and cancer.白细胞介素-29在免疫和癌症中的作用。
Crit Rev Oncol Hematol. 2016 Oct;106:91-8. doi: 10.1016/j.critrevonc.2016.08.002. Epub 2016 Aug 10.